ROSINA, SILVIA
 Distribuzione geografica
Continente #
EU - Europa 2.288
AS - Asia 510
NA - Nord America 455
Continente sconosciuto - Info sul continente non disponibili 101
SA - Sud America 35
AF - Africa 9
Totale 3.398
Nazione #
IT - Italia 2.195
US - Stati Uniti d'America 411
SG - Singapore 188
CN - Cina 121
BD - Bangladesh 85
VN - Vietnam 67
FR - Francia 32
BR - Brasile 19
CA - Canada 18
DE - Germania 13
FI - Finlandia 13
HK - Hong Kong 13
GB - Regno Unito 8
MX - Messico 8
NL - Olanda 8
JP - Giappone 7
AR - Argentina 6
IN - India 6
ID - Indonesia 5
CO - Colombia 4
ES - Italia 4
UA - Ucraina 4
CR - Costa Rica 3
JM - Giamaica 3
RU - Federazione Russa 3
ZA - Sudafrica 3
GT - Guatemala 2
IQ - Iraq 2
IR - Iran 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
TR - Turchia 2
AT - Austria 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CL - Cile 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EG - Egitto 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
MA - Marocco 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
SE - Svezia 1
SN - Senegal 1
SV - El Salvador 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.298
Città #
Genoa 910
Genova 711
Rapallo 261
Vado Ligure 220
San Jose 98
Singapore 95
Ashburn 41
Beijing 29
Ho Chi Minh City 26
New York 24
Lauterbourg 22
Hanoi 13
Santa Clara 13
Council Bluffs 12
Helsinki 12
Hong Kong 12
Los Angeles 12
Milan 11
Buffalo 10
Chicago 9
Frankfurt am Main 9
Bordighera 7
Tokyo 7
Boardman 6
Bologna 6
Mexico City 6
Seattle 6
Amsterdam 5
Dallas 4
Haiphong 4
Naples 4
Orem 4
Rome 4
Alessandria 3
Chennai 3
Gresham 3
Kingston 3
Kyiv 3
Miami 3
Montreal 3
Philadelphia 3
San Diego 3
São Paulo 3
Toronto 3
Venice 3
Adana 2
Asheboro 2
Atlanta 2
Barcelona 2
Barrington 2
Biên Hòa 2
Bratislava 2
Brooklyn 2
Can Tho 2
Canton 2
Cleveland 2
Fredericksburg 2
Garanhuns 2
Grand Rapids 2
Guangzhou 2
Guatemala City 2
Indpls 2
Kensington 2
Las Vegas 2
London 2
Managua 2
Medellín 2
Medford 2
Minneapolis 2
Montoro 2
Muscat 2
Omaha 2
Phuket 2
Piscataway 2
Princeton 2
Riverside 2
Rosarno 2
San José 2
Tampa 2
Temecula 2
Washington 2
Zhengzhou 2
Abbeville 1
Alajuela 1
Albuquerque 1
Arcata 1
Baghdad 1
Banyuwangi 1
Bari 1
Basingstoke 1
Belgrade 1
Belleville 1
Benito Juarez 1
Blumenau 1
Boca Toma 1
Bogotá 1
Boise 1
Boston 1
Bridgetown 1
Brockton 1
Totale 2.741
Nome #
Development and validation of a composite disease activity score for juvenile dermatomyositis 192
Development and validation of a composite disease activity score for measurement of muscle and skin involvement in juvenile dermatomyositis 174
Development and testing of a hybrid measure of muscle strength in juvenile dermatomyositis for use in routine care 173
A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis 169
Innovative Research Design to Meet the Challenges of Clinical Trials for Juvenile Dermatomyositis 163
Recent therapeutic advances in juvenile idiopathic arthritis 159
Tapering Canakinumab Monotherapy in Patients with Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results from an Open‐label, Randomized Phase IIIb/IV Study 151
Determinants of discordance between criteria for inactive disease and low disease activity in juvenile idiopathic arhritis 135
Analysis of arthritis flares after achievement of inactive disease with methotrexate monotherapy in juvenile idiopathic arthritis 127
Muscle Expression of Type I and Type II Interferons Is Increased in Juvenile Dermatomyositis and Related to Clinical and Histologic Features 125
Information technology in paediatric rheumatology 124
Open issues in the assessment and management of pain in juvenile idiopathic arthritis 123
Development and testing of reduced versions of the MMT-8 in juvenile dermatomyositis 121
Is Anti-NXP2 Autoantibody a Risk Factor for Calcinosis and Poor Outcome in Juvenile Dermatomyositis Patients? Case Series 115
Nailfold videocapillaroscopy in juvenile dermatomyositis: detailed correlations between microvascular abnormalities with clinical and laboratory parameters from an observational retrospective single-center study 109
Is macrophage activation syndrome in Kawasaki disease underrecognized? 103
A prediction rule for polyarticular extension in oligoarticular-onset juvenile idiopathic arthritis 99
Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritis 99
Novel biomarkers for prediction of outcome and therapeutic response in juvenile idiopathic arthritis 92
Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management 89
Giant Urticaria and Acral Peeling in a Child with Coronavirus Disease 2019 83
Frequency of remission achievement in the pre-treat-to-target decade in juvenile idiopathic arthritis 77
Multisystem Inflammatory Syndrome in Children: Unique Disease or Part of the Kawasaki Disease Spectrum? 74
Defining criteria for disease activity states in juvenile dermatomyositis based on the Juvenile Dermatomyositis Activity Index 72
Forecasting Achievement of Inactive Disease in Juvenile Idiopathic Arthritis with Artificial Intelligence 70
DADA-ism (2) 70
Treating juvenile dermatomyositis to target: Paediatric Rheumatology European Society/Childhood Arthritis and Rheumatology Research Alliance-endorsed recommendations from an international task force 56
Outcome Scores in Pediatric Rheumatology 56
Standardised nailfold capillaroscopy in children with rheumatic diseases: a worldwide study. 50
Towards the definition of disease phenotypes in paediatric SAPHO syndrome: a national multicentric study 47
Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinib 30
Efficacy of combined JAK1/2 inhibition and cyclosporine in paediatric-onset Still’s disease with lung involvement: a case report 29
Treat-to-Target in Pediatric Rheumatic Diseases 24
Discordance between non-zero physician's global scores and absence of active joints in juvenile idiopathic arthritis: multicenter vs. single-center cohorts 12
Toward a Treat‐to‐Target Strategy in Juvenile Dermatomyositis: What Are the Suitable Targets and Optimal Timing of Their Achievement? 6
Totale 3.398
Categoria #
all - tutte 13.357
article - articoli 12.857
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.214


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022237 0 31 5 15 9 15 9 42 21 33 15 42
2022/2023299 25 37 2 22 52 37 1 25 55 1 40 2
2023/2024217 6 28 5 36 20 13 18 14 17 14 11 35
2024/2025618 29 44 44 27 49 47 47 138 25 28 77 63
2025/20261.358 161 31 45 86 168 92 168 56 111 151 121 168
2026/2027131 128 3 0 0 0 0 0 0 0 0 0 0
Totale 3.398